Presentations

08:00

Predictive value of early continuous glucose monitoring–detected hyperglycaemia for post-transplant diabetes mellitus among non-diabetic kidney transplant recipients

Abhilash Tirkey (IN)

Bio Abstract

08:07

SGLT-2i use and risk of mortality and heart failure in kidney transplant recipients with type 2 diabetes.

Babak Orandi (US)

Bio Abstract

08:14

Preoperative Assessment of Muscle Mass in Kidney Transplant Recipients: Comparison of DXA, CT, and InBody, and Their Predictive Value for Functional Impairment

Dahyun Jung (KR)

Bio Abstract

08:21

Temporal changes in gut microbiota across different phases after kidney transplantation

Yunchao Wang (CN)

Bio Abstract

08:28

Impact of Changes in Smoking Behavior Before and After Kidney Transplantation on Graft and Cardiovascular Outcomes: A Nationwide Cohort Study

Sangwan Kim (KR)

Bio Abstract

08:35

Metabolic bariatric surgery vs GLP-1 receptor agonists in dialysis patients with diabetes and obesity: a target trial emulation study

Babak Orandi (US)

Bio Abstract

08:42

Perspectives and experiences of clinicians on substance use in patients with chronic kidney disease and kidney transplants

Anastasia Hughes (AU)

Bio Abstract